Jørgensen K, Nowak P, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3731229 A1, 2022-06-21.
Johnson M A, Klinger H, Anderson J P. "Method for the Synthesis of 2-Methyl-5-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol" [P]. US Patent, US 10826317 B2, 2022-12-12.
发明人罗永刚,孙丽萍,黄志刚. "A Process for Preparing High-Purity 2-Methyl-5-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol" [P]. 中国发明专利, 专利号 CN 109009471 B, 授权公告日 2020-03-20.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2015, 2407, (3), 6567-6575.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2025, 1375, (3), 3823-3845.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-5-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol Using HRMS and NMR". Molecules, 2011, 1034, 3197-3210.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2014, 1105, (5), 251-271.